Acting US FDA Chief Scientist Tapped, As Borio Moves To White House Biodefense Detail
FDA promotes Denise Hinton to acting chief scientist after Luciana Borio is detailed to the National Security Council for biodefense work
You may also be interested in...
Scientists from US FDA and other health agencies are working to develop and rapidly approve tests that can clearly and quickly detect Zika virus from Dengue fever. But without a steady source of funding for countermeasures, progress to fight Zika may slow, even while the emergence of mosquito-borne diseases accelerates, agency officials said.
Manufacturers would have full responsibility for writing, producing, and ultimately delivering the new patient medication information document with their products, if FDA decides the industry should fully adopt the unit-of-use packaging.
The FDA commissioner also does not want the agency setting goals for rare disease treatment development.